0001144204-18-064917.txt : 20181217 0001144204-18-064917.hdr.sgml : 20181217 20181217162148 ACCESSION NUMBER: 0001144204-18-064917 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181211 FILED AS OF DATE: 20181217 DATE AS OF CHANGE: 20181217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brzeczko Albert W CENTRAL INDEX KEY: 0001455740 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10113 FILM NUMBER: 181238367 MAIL ADDRESS: STREET 1: C/O ACURA PHARMACEUTICALS, INC. STREET 2: 660 N. NORTH COURT CITY: PALATINE STATE: IL ZIP: 60067 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACURA PHARMACEUTICALS, INC CENTRAL INDEX KEY: 0000786947 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 110853640 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 616 N. NORTH COURT, SUITE 120 CITY: PALATINE STATE: IL ZIP: 60067 BUSINESS PHONE: 847-705-7709 MAIL ADDRESS: STREET 1: 616 N. NORTH COURT, SUITE 120 STREET 2: . CITY: PALATINE STATE: IL ZIP: 60067 FORMER COMPANY: FORMER CONFORMED NAME: HALSEY DRUG CO INC/NEW DATE OF NAME CHANGE: 19920703 4 1 tv509292_4.xml OWNERSHIP DOCUMENT X0306 4 2018-12-11 0 0000786947 ACURA PHARMACEUTICALS, INC ACUR 0001455740 Brzeczko Albert W C/O ACURA PHARMACEUTICALS, INC. 616 N. NORTH COURT SUITE 120 PALATINE IL 60067 0 1 0 0 VP Pharmaceutical Sciences APT Restricted Stock Unit 0.01 2018-12-11 4 A 0 102000 A Common Stock 102000 102000 D Stock Option 0.151 2018-12-11 4 A 0 34000 A 2019-12-11 2023-12-11 Common Stock 34000 34000 D Awarded under the Acura Pharmaceuticals Inc. 2017 Restricted Stock Unit Award Plan (the "Plan"). Par value of $.01 must be paid by Reporting Person upon exchange of Restricted Stock Units for stock. 100% of Restricted Stock Units vest on December 11, 2019 or earlier if Reporting Person's service as an employee of Issuer is terminated by Issuer without Cause (as defined in the Plan) or due to Reporting Person's death or Disability (as defined in the Plan) or a qualifying change of control occurs. Distributions in respect of vested Restricted Stock Units will be made in three equal installments on the first business day of each of January 2021, 2022, and 2023 or earlier upon a qualifying change of control which also meets certain criteria of Section 409A of the Internal Revenue Code. Not Applicable. Awarded under the Acura Pharmaceuticals Inc. 2016 Stock Option Plan. Exercise price is closing price of Issuer's common stock on December 11, 2018. Option vesting and exercisability is accelerated upon a qualifying change of control. /s/ Albert W. Brzeczko 2018-12-17